FDA Asks Feedback on Tobacco Seller Training Info
Published Date: 2/25/2026
Notice
Summary
The FDA is asking for public feedback on their plan to keep collecting info about tobacco retailer training programs. These programs help stores teach employees the rules about selling tobacco safely and legally. If approved, this will continue without extra costs but keep the training standards clear and up-to-date. Comments are due by March 27, 2026, so retailers and the public can weigh in!
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Time burden for retailer training records
The FDA estimates 237,113 retail establishments keep records for tobacco retailer training programs each year. FDA estimates one-time development for newly creating programs (18,969 establishments) totals 474,225 hours (25 hours per respondent for development activities) and annual recordkeeping totals 569,071 hours across establishments; FDA reports the total estimated annual hours changed from 2,183,780 to 1,043,296 hours, a decrease of 1,140,484 hours.
Guidance recommends tests, annual refreshers, 4-year records
FDA's guidance recommends retailers train employees on Federal tobacco sale rules, age verification, refusals, and other topics; require a written test before selling tobacco; provide refresher training at least annually; conduct internal compliance checks every 6 months; and retain training records for 4 years so they can show evidence during the 48-month civil money penalty period. Commenters and FDA say these recommendations are linked to preventing youth access to tobacco products.
Program remains voluntary; no FDA approvals now
FDA states the Tobacco Retailer Training Programs guidance is voluntary: retailers are not required to implement programs or submit them to FDA, and FDA will not recognize or approve existing training programs or certifications because it has not promulgated regulations establishing approved programs. FDA also states there are no capital or operating and maintenance costs associated with this information collection.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09767 — Oscar Bobo: Final Debarment Order
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He ignored the chance to defend himself, so the ban started on May 15, 2026. This means no drug imports from him for a while, but he can apply to end the ban anytime if he meets FDA’s conditions.
2026-09448 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3
The FDA is asking for approval to collect info for the third group in its Real Cost Campaign, which teaches kids about the dangers of tobacco. This helps the FDA improve its anti-smoking messages and protect young people’s health. Comments on this info collection are open until June 12, 2026, with no new costs for participants.
2026-09543 — Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting
The FDA wants your thoughts on how drug companies report problems after their products hit the market. This affects drug makers and healthcare folks who keep track of side effects. They’re asking for comments by July 13, 2026, to help improve the process without adding extra costs or paperwork.
2026-09544 — Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.
The FDA is inviting the public to comment on the renewal of special approval for two cigarette products by 22nd Century Group Inc. These products claim to lower health risks compared to regular cigarettes. If approved, the renewal keeps these products on the market with their modified risk status, affecting smokers and the tobacco industry starting May 13, 2026.
2026-09335 — Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection
Hey there! This update is all about a new medical device that helps doctors quickly find germs and their resistance traits in people who might have bone infections. It affects hospitals and labs by officially classifying this device, making it easier and faster to diagnose tough infections. The change kicks in soon, helping patients get the right treatment without delay—and it could save money by avoiding wrong meds!
2026-09368 — Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability
The FDA is setting clear rules for certain new tobacco products like e-cigarettes and nicotine pouches that don’t have official approval yet. Companies selling these products without permission might face enforcement actions starting now, so they need to get authorized or risk penalties. This helps protect public health and keeps the market fair and safe.
Previous / Next Documents
Previous: 2026-03770 — Noise Exposure Map Notice: Louisville Muhammad Ali International Airport (SDF)
The FAA has officially approved the noise maps for Louisville Muhammad Ali International Airport, showing current and future noise levels around the airport. This means local communities and officials now have a clear picture of noise impact, helping guide future plans to keep neighborhoods peaceful. The approval took effect on February 23, 2026, and could lead to new steps to reduce noise and protect residents.
Next: 2026-03772 — Agency Information Collection Activities; Proposed Collection; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds
The FDA wants feedback on how medicated animal feed makers keep their records to make sure everything’s safe and up to date. This affects companies that produce medicated feeds, and they have until April 27, 2026, to share their thoughts. No big money changes yet, just a chance to improve how info is collected and stored.